The Patent Finder

Nucleoside Phosphoramidates

Gilead Sciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 61/179,923, filed May 20, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,629,263Nucleoside Phosphoramidates
In force
 · High confidence
Gilead Sciences, Inc.In force
High confidence
US 8,633,309Nucleoside Phosphoramidates
In force
 · Medium confidence
Gilead Sciences, Inc.In force
Medium confidence
US 8,642,756Nucleoside Phosphoramidates
In force
 · High confidence
Gilead Sciences, Inc.In force
High confidence
US 8,735,569Nucleoside Phosphoramidates
In force
 · High confidence
Gilead Sciences, Inc.In force
High confidence
US 9,206,217Nucleoside Phosphoramidates
In force
 · High confidence
Gilead Sciences, Inc.In force
High confidence
US 9,284,342Nucleoside Phosphoramidates
In force
 · High confidence
Gilead Sciences, Inc.In force
High confidence
US 8,618,076Nucleoside Phosphoramidates
In force
 · High confidence
Gilead Sciences, Inc.In force
High confidence
US 9,637,512Nucleoside Phosphoramidates
In force
 · High confidence
Gilead Sciences, Inc.In force
High confidence
Application 18/054,489Nucleoside Phosphoramidates
Abandoned
Abandoned Aug 2, 2023
Gilead Sciences, Inc.AbandonedAbandoned Aug 2, 2023
Application 18/343,311Nucleoside Phosphoramidates
Abandoned
Abandoned Feb 29, 2024
Gilead Sciences, Inc.AbandonedAbandoned Feb 29, 2024
1 more patent in this group · Pro
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
Upgrade to Pro
8 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited